TDH HOLDINGS INC

PETZ represents the publicly traded common stock of PetMed Express, Inc., a company that operates as a direct-to-consumer pet pharmacy in the United States. The ticker PETZ trades on the Nasdaq Global Select Market. The stock gives investors exposure to the pet medication and pet health products retail sector. PetMed Express primarily sells prescription and non-prescription pet medications, along with health and wellness products, directly to consumers through its website and other channels.

Recent performance for PETZ depends on the latest market activity, which changes daily. The stock detail page for PETZ typically shows current price, daily change, and multi-period returns so investors can see how the shares have moved over recent sessions and weeks. For the most accurate and up-to-date performance figures, refer to the latest PETZ data displayed on this page rather than relying on any static summary.

Useful valuation metrics for PETZ include the price-to-earnings ratio, price-to-sales ratio, price-to-book ratio, and enterprise value relative to EBITDA. Because PetMed Express operates in a competitive retail pharmacy space, investors may also compare its gross margin and free cash flow yield against peers. These metrics help frame whether PETZ is trading at a premium or discount relative to its own history and similar companies, though they should be considered alongside business fundamentals.

PETZ can be traded during the regular U.S. market session, which runs from 9:30 a.m. to 4:00 p.m. Eastern Time on weekdays, excluding market holidays. Many brokers also offer pre-market and after-hours trading, though liquidity and spreads may be less favorable during those extended sessions. Investors should confirm their brokerage's specific trading hours and order types before placing trades in PETZ.

Analyzing financial performance for PETZ involves reviewing PetMed Express's quarterly and annual reports, including the income statement, balance sheet, and cash flow statement. Key areas to examine include revenue trends, gross margin, operating expenses, net income, and free cash flow. Investors can also track same-customer sales, new order growth, and prescription volumes. These figures are reported in SEC filings and company earnings releases, which provide the most reliable basis for evaluating PETZ's financial trajectory.

PETZ faces risks tied to intense competition from large online and brick-and-mortar pet retailers, pressure on medication margins, and reliance on prescription volumes. Regulatory changes affecting pet medication sales, supply chain disruptions, and shifting consumer spending on pet care can also impact results. Additionally, as a relatively small-cap company, PETZ may experience greater stock price volatility and lower trading liquidity than larger, more diversified corporations.